This article was originally published in Start Up
AlphaGenics is launching a consumer-focused nutrigenomics business. It will track its client's diets and compare their food intake to changes in their gene expression, over time building a database that the company believes will become a valuable research tool for advancing the emerging science of nutrigenomics.
You may also be interested in...
Paths to commercialization are uncertain in nutrigenomics, an emerging science which seeks to identify gene-food interactions that differ among subpopulations and between individuals and to personalize diets to prevent disease.
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)